Agendia
Jeffrey G. is a skilled Molecular Oncology Specialist at Agendia, with prior experience as Director of Business Development at Primum and Clinical Account Executive at Lucence. Jeffrey has a strong background in business development and sales within the biotechnology and genetics sectors, having held various roles including Business Development Manager at Menarini Silicon Biosystems and Senior Account Executive at Ambry Genetics. Jeffrey's experience includes territory management, contract negotiation, and new product introduction. Earlier career stages involved technical support in the refinery process as a District Sales Representative at Nalco Champion and hands-on engineering work as a Co-op Chemical/Process Engineer at The Perry Group. Jeffrey earned a Bachelor's degree in Chemical Engineering from The Ohio State University, where participation in extracurricular activities fostered team collaboration and networking skills.
This person is not in any offices
Agendia
Agendia is the only molecular diagnostics company focused solely on breast cancer. With their groundbreaking genomic testing, they generate reliable and meaningful clinical data about the unique biology of a woman’s breast cancer.